BlueRock Therapeutics Competitors and Similar CompaniesClear all
BlueRock Therapeutics's competitors and similar companies include Regenxbio and Froceth.
 Regenxbio Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases. |  Froceth Froceth is a biotechnology company manufacturing advanced therapy medicinal products (ATMPs). | ||
Founding Date | Founding Date 2016 | Founding Date 2009 | Founding Date 2014 |
Type | Type Subsidiary | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Toronto, CA Berlin, DE New York, US | Locations Rockville, US HQ | Locations Vilnius, LT HQ |
Employees | Employees 477 | Employees 4018% increase | Employees 7 |
Funding | |||
Total funding raised | Total funding raised $ 225m | Total funding raised $ 118.9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Regenxbio
HQ
Rockville, US
Employees
401↑ 8% increase
Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases.
View companyFroceth
HQ
Vilnius, LT
Employees
7
Froceth is a biotechnology company manufacturing advanced therapy medicinal products (ATMPs).
View company